Bank Of New York Mellon Corp Kiniksa Pharmaceuticals, Ltd. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $1.45 Million - $2.17 Million	127,347 New	127,347 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $47,736 - $65,588	4,891 Added 4.05%	125,528 $1.61 Million
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $124,366 - $186,713	-16,364 Reduced 11.94%	120,637 $1.17 Million
Q1 2022 May 11, 2022	BUY	$9.3 - $12.37 $28,783 - $38,285	3,095 Added 2.31%	137,001 $1.36 Million
Q4 2021 Feb 11, 2022	SELL	$10.39 - $15.15 $11,335 - $16,528	-1,091 Reduced 0.81%	133,906 $1.58 Million
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $41,436 - $59,044	3,638 Added 2.77%	134,997 $1.54 Million
Q2 2021 Aug 11, 2021	SELL	$13.22 - $19.09 $40,400 - $58,339	-3,056 Reduced 2.27%	131,359 $1.83 Million
Q1 2021 May 13, 2021	SELL	$16.68 - $23.97 $40,832 - $58,678	-2,448 Reduced 1.79%	134,415 $2.49 Million
Q4 2020 Feb 09, 2021	BUY	$14.8 - $21.15 $679,453 - $970,975	45,909 Added 50.47%	136,863 $2.42 Million
Q3 2020 Nov 12, 2020	BUY	$15.21 - $25.53 $204,376 - $343,046	13,437 Added 17.33%	90,954 $1.39 Million
Q2 2020 Aug 12, 2020	BUY	$15.08 - $26.0 $441,768 - $761,670	29,295 Added 60.75%	77,517 $1.98 Million
Q1 2020 May 06, 2020	BUY	$11.0 - $19.76 $21,978 - $39,480	1,998 Added 4.32%	48,222 $746,000
Q4 2019 Feb 14, 2020	SELL	$5.24 - $12.96 $31,382 - $77,617	-5,989 Reduced 11.47%	46,224 $511,000
Q3 2019 Nov 07, 2019	SELL	$8.15 - $15.88 $33,887 - $66,029	-4,158 Reduced 7.38%	52,213 $444,000
Q2 2019 Aug 12, 2019	BUY	$13.2 - $20.39 $124,436 - $192,216	9,427 Added 20.08%	56,371 $764,000
Q1 2019 May 14, 2019	BUY	$15.93 - $26.59 $420,137 - $701,284	26,374 Added 128.22%	46,944 $848,000
Q4 2018 Feb 11, 2019	BUY	$16.25 - $28.09 $56,858 - $98,286	3,499 Added 20.5%	20,570 $578,000
Q3 2018 Nov 09, 2018	BUY	$13.23 - $30.93 $225,849 - $528,006	17,071 New	17,071 $0

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$33.1 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.42 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.13 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$860,794
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$654,000
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account